secwatch.observer — SEC 8-K summary
======================================

Issuer:     Vireo Growth Inc. (VREOF)
CIK:        0001771706
Form:       8-K
Filed at:   2026-08-05T21:16:01+00:00
Accession:  0001104659-26-091266
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.80
Item codes: 1.01, 7.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Vireo Growth to acquire four Ohio cannabis companies for ~$210M in stock
------------------------------------------------------------------------

- Acquires FarmaceuticalRx LLC for ~$139.5M in stock; FRX has $23.8M closing EBITDA.
- Acquires FarmaceuticalRx2 LLC for ~$19.2M in stock (after adjustments) plus assumes ~$50.9M debt.
- Acquires Canoe Hill Ohio for ~$34.8M in stock (5.7x $6.1M EBITDA) and CAOH for ~$16.0M in stock (5.7x $2.8M EBITDA).
- CEO John Mazarakis is a seller in CAOH transaction (related party); will receive 421,344 shares, increasing his stake by 128.5%.
- All deals include performance-based clawback: up to 25% of shares forfeited if 2027 EBITDA targets missed and stock price >$31.50.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1771706/000110465926091266/0001104659-26-091266-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1771706/000110465926091266/tm2621363d5_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-26-091266

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer